Fertility drugs and ovarian cancer

Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
P G ArtiniA R Genazzani

Abstract

Recent case reports of ovarian cancer associated with infertility treatment raise the question of a possible etiopathogenetic role of fertility drugs in ovarian cancer. In this paper, the possible relationship between infertility treatment and ovarian cancer is reviewed with respect to the epidemiological and pathogenetic profiles of ovarian cancer and the potential risk factors associated with fertility drugs; a case report review and a critical reappraisal are also provided within this article. Currently available data in the literature, from epidemiological studies and case reports, suggest that a direct causal effect of infertility treatment on ovarian cancer seems unlikely. Since infertile women are likely to have a higher risk for the development of ovarian cancer, and the role of fertility drugs in the etiopathogenesis of ovarian carcinoma is not established, a close clinical examination of infertile patients before, during and after infertility treatment is recommended. Moreover, further investigation is required to resolve the question of the possible association between fertility drugs and ovarian cancer through large prospective epidemiological or retrospective case-control studies.

References

Jul 28, 1979·Lancet·J T CasagrandeB E Henderson
Jan 1, 1978·Acta Obstetricia Et Gynecologica Scandinavica·L G FribergC B Korsten
Oct 2, 1976·British Medical Journal·S ChakravartiJ W Studd
Dec 1, 1975·American Journal of Obstetrics and Gynecology·B V Stadel
Oct 1, 1992·International Journal of Epidemiology·E Lund
Mar 1, 1992·American Journal of Obstetrics and Gynecology·G L Goldberg, C D Runowicz
Jun 22, 1991·Lancet·S LowryR Atkinson
Oct 1, 1991·Gynecologic Oncology·F ParazziniM Fasoli
Sep 16, 1989·BMJ : British Medical Journal·R Kulkarni, J M McGarry
Jul 29, 1989·BMJ : British Medical Journal·S Fishel, P Jackson
Oct 1, 1989·American Journal of Obstetrics and Gynecology·R NakanoA Ooshima
Oct 1, 1989·British Journal of Cancer·M BoothP Smith
Dec 1, 1989·European Journal of Cancer & Clinical Oncology·S Franceschi
Jul 1, 1989·American Journal of Obstetrics and Gynecology·P HartgeH J Norris
Feb 1, 1988·Biochemical Pharmacology·B Styrt, M S Klempner
Jan 1, 1988·Research in Developmental Disabilities·J L MatsonN Long
Dec 15, 1985·American Journal of Obstetrics and Gynecology·P E GravesR L Stouffer
Jan 1, 1987·Journal of the National Cancer Institute·B L HarlowS Lofton
Apr 1, 1987·Journal of in Vitro Fertilization and Embryo Transfer : IVF·M E Carter, D N Joyce
Nov 1, 1988·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M BengtssonJ Rydström
May 1, 1987·American Journal of Epidemiology·E RonD Serr
Jan 1, 1986·Acta Obstetricia Et Gynecologica Scandinavica·H Ben-HurD Rosenman
Feb 1, 1985·Journal of the Royal Society of Health·M C Pike, C Chilvers
Jul 17, 1971·Lancet·M F Fathalla
Mar 1, 1974·American Journal of Epidemiology·D J JolyI D Bross
Sep 1, 1984·The Journal of Clinical Endocrinology and Metabolism·R L StoufferE A Surwit
May 1, 1984·American Journal of Epidemiology·P C NascaT Caputo
Jul 1, 1983·The Journal of Clinical Investigation·Y Oka, D N Orth
Jan 1, 1983·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·T J ColganC H Fox
Jul 15, 1982·Cancer·D W CramerC A Wojciechowski
Oct 21, 1982·The New England Journal of Medicine·D W CramerR C Knapp
Jan 1, 1982·Acta Obstetricia Et Gynecologica Scandinavica·M Atlas, J Menczer
Nov 1, 1982·British Journal of Obstetrics and Gynaecology·P N Bamford, S J Steele
Nov 5, 1994·Lancet·H O AdamiP O Janson
Sep 22, 1994·The New England Journal of Medicine·M A RossingS G Self
Apr 17, 1993·Lancet·W WillemsenR Rolland
Mar 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·T YanoA V Schally
Mar 1, 1994·Fertility and Sterility·J G Schenker, Y Ezra

❮ Previous
Next ❯

Citations

Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·R A KeriJ H Nilson
Jul 13, 1999·Human Reproduction·M H Johnson
Aug 15, 2013·The Cochrane Database of Systematic Reviews·Ivana RizzutoLesley A Smith
Dec 2, 2006·Journal of Magnetic Resonance Imaging : JMRI·Michal NeemanBatya Cohen
Jun 18, 2019·The Cochrane Database of Systematic Reviews·Ivana RizzutoLesley A Smith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.